A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

April 26, 2017

Study Completion Date

June 16, 2017

Conditions

DiabetesHealthy

Interventions

DRUG

Semaglutide

Oral administration once daily alone or together with levothyroxine or Placebo

DRUG

SNAC

Oral administration once daily alone or together with levothyroxine or semaglutide

DRUG

Levothyroxine

Oral administration alone or together with SNAC or oral semaglutide

DRUG

Placebo

Oral administration once daily together with semaglutide

Trial Locations (1)

Novo Nordisk Investigational Site, Berlin